Assessment of an iPhone Application on Glycemic Control in Type 1 Diabetes
Diabetes Mellitus, Type 1
About this trial
This is an interventional treatment trial for Diabetes Mellitus, Type 1
Eligibility Criteria
Inclusion Criteria:
- T1DM as defined by 2008 Canadian Diabetes Association (CDA,2008)guidelines, with duration ≥ 1 year
- Age 11-16 years, inclusive at enrollment in the trial
- 2 of the participant's last 3 A1C results prior to enrollment, including the most recent, falling between 8.0% - 10.5%
- Have been followed for at least 6 months in the current diabetes clinic
Exclusion Criteria:
- Non-English speaking adolescents as the version of bant being used in the randomized control trial (RCT) is only offered in English at this time.
Sites / Locations
- Trillium Health Partners
- The Hostpital for Sick Children
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
bant Group
Control Group
Subjects in the bant Group will receive care as usual, as well as an iPhone loaded with the bant iPhone application and a bluetooth enabled glucometer. Participants will have their A1C levels measured every 3 months (for 1 year), and also complete questionnaires/interviews relating to their diabetes management and lifestyle.
Subjects in the control group will continue care as usual with their diabetes team, without supplementation of the bant application. Participants will have their A1C levels measured every 3 months (for 1 year), as well as complete questionnaires/interviews relating to their diabetes management and lifestyle.